13F-HR filed by Artia Global Partners LP
Artia Global Partners LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 25 holding rows worth $262,395,844.
- Accession
- 0001420506-23-000693
- Filer
- CIK 1937964
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 25 entries on the cover page, a total value of $262,395,844 stated on the cover page (in dollars after the unit check, H1), rows summing to $262,395,844 with VALUE read as dollars as filed, 13F file number 028-23071. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NOVO-NORDISK A S ADR | 670100205 | ADR | 371,055 | $50,218,584 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 104,328 | $38,167,356 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 85,204 | $32,277,831 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 264,200 | $29,312,990 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 99,267 | $19,505,966 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 90,821 | $14,677,582 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 74,719 | $13,421,027 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 504,615 | $10,803,807 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 30,000 | $8,307,600 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 51,175 | $6,576,499 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 37,108 | $5,574,364 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 45,000 | $5,374,800 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 77,759 | $5,272,060 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 15,971 | $3,795,508 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 28,217 | $2,920,177 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 5,088 | $2,801,911 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 22,321 | $2,455,310 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 41,600 | $2,201,472 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 7,114 | $2,054,381 | dollars as filed | |
| MODERNA INC | 60770K907 | CALL | 10,000 | $1,796,200 | dollars as filed | call |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 130,913 | $1,230,582 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 39,951 | $1,043,920 | dollars as filed | |
| WATERS CORP COM | 941848103 | Stock | 2,845 | $974,640 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 23,883 | $882,477 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 30,000 | $748,800 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-000693 | this filing | 2023-02-14 | acceptance time not in the bulk data set |